ABSTRACT Using a recently isolated human basic somatomedin (basic SM) similar to insulin-like growth factor I (IGF-I), we studied both the photoaffinity-labeled and unlabeled basic-SM receptor solubilized from human placental cell membranes. Unlike the result with the insulin receptor, high yields of soluble basic-SM-binding activity are obtained with Triton X-100. The soluble basic-SM receptor retains high-affinity (Kd 0.3 nM) peptide-specific binding of basic SM, similar to the binding present in particulate placenta membranes; the receptor exhibits a comparatively low affinity for insulin (k d 3 FAM). On Sepharose 6B, like the crude soluble insulin receptor, the basic-SM receptor migrates as a species with an apparent Stokes radius of 7.2 nm; unlike the insulin receptor, the basic-SM receptor does not, under similar conditions, yield a smaller binding species (apparent Stokes radius 3.8 nm). Upon photoaffinity labeling with "I-labeled basic SM, one principal specifically labeled constituent is detected. Upon gel electrophoresis in the presence of 2-mercaptoethanol, the photolabeled constituent, like the insulin receptor, migrates as a species with an apparent molecular weight of about 140,000; in the absence of reducing agent, a molecular weight greater than 240,000 is observed. Lectin-agarose affinity chromatography yields a 30-fold purification both of the basic-SM-binding activity and the photolabeled constituent. Anti-insulin receptor antibody does not appear to precipitate the basic-SM receptor. We conclude that the basic-SM receptor of human placenta is a glycoprotein, remarkably similar to (an isoreceptor) but distinct from the insulin receptor previously characterized in this tissue.
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The somatomedins (SM) are a group of growth hormone-dependent, serum-borne, polypeptide growth factors that have in common the ability to stimulate proteoglycan synthesis in cartilage and to mimic the actions of insulin in a variety of extraskeletal tissues. The somatomedins account for the insulinlike activity in human serum that is not neutralized by anti-insulin antibody (so-called nonsuppressible insulin-like activity or NSILA; recently renamed insulin-like growth factors or IGFs). Recent evidence suggests that all of the reported somatomedins may fall into two main groups based on their isoelectric points. The basic group (pIs greater than 7.4) includes insulin-like growth factor-I (IGF-I) (1) , SM-C (2), and a basic SM that has been purified in our laboratory (3) . The acidic-neutral group (pI less than 7.4) includes IGF-II (1), SM-A (4), and multiplication-stimulating activity (5) . The basic group of somatomedins are highly similar in terms of their molecular weights, pls, NH2-terminal amino acid sequences (1-3), and immunoreactivity (3, 6, 7) . IGF-I (similar to our basic SM) and IGF-II have different NH2-terminal amino acid sequences but share a sequence homology with each other and with proinsulin (8) . Thus, there is a complex relationship between insulin, the somatomedins, and the peptide-specific receptors for each of these polypeptides. Although distinct receptors for the somatomedins have been detected in fat cells (9) , fibroblasts (9, 10), and placenta (11), the. sequence homologies lead to cross-specificity of binding at the receptor sites, so that insulin at high concentrations (micromolar) can occupy the SM receptors and vice versa.
In view ofthe cross-specificity ofthe ligand recognition properties ofthe receptors for insulin and the SMs, we have become interested in comparing the physicochemical properties of the insulin receptor with those of the receptors for the SMs. In the present work, we report the solubilization, photoaffinity labeling, characterization, and partial purification of the human placenta receptor for human basic SM. Our results indicate a high degree of physiocochemical similarity between the basic-SM receptor and the receptor for insulin.
MATERIALS AND METHODS lodination of Basic SM and Insulin. Highly purified basic SM was isolated as reported (3) . This basic SM had a potency of4000 units/mg by hypophysectomized rat cartilage bioassay. Insulin was a gift from Eli Lilly. Peptides were iodinated by a modification of the chloramine-T method (6) to specific activities of 100-150 ,uCi of basic SM and 80-100 pCi of insulin per Ag (1 Ci = 3.7 x 1010 becquerels).
Preparation ofMembranes and Membrane Extract. A crude "microsomal" membrane fraction from term human placenta cells was prepared from the placental basal plate by homogenization and differential centrifugation, essentially as described (12, 13) . Membranes were solubilized (6 mg of membrane protein per ml of detergent solution) for 30 min at 240C with 0.5% Triton X-100 or 0.15-0.5% Ammonyx-LO (Onyx Chemical, Hoboken, NJ) in 50 mM Tris HCl (pH 7.4). The extract was clarified by centrifugation at 150,000 X g for 70 min at 4°C. Before use, Ammonyx-LO-solubilized membrane preparations were made 0.5% in Triton X-100 and were dialyzed for 17 hr at 40C against 0.5% Triton X-100 in 50 mM Tris HCl (pH 7.4).
Binding Assay. Solubilized membrane protein (=50 ,ug of protein in 0.1 ml) was incubated with radiolabeled basic SM (10,000-100,000 cpm) or insulin ("'100,000 cpm) with or without unlabeled basic-SM or insulin (==1 ,ug of unlabeled peptide per ml) in Tris HCl buffer (pH 7.4) containing 5 mg of bovine serum albumin per ml (final vol, 0.3 ml). Samples in 12 x 75 mm polystyrene tubes were equilibrated overnight at 4°C Fig. 1A ). From the binding-competition curves (Fig.  1B) , the inhibition constant (14) for the binding of unlabeled was detected with either oftwo methods for receptor detection ( Fig. 2 A and B) . In contrast, in agreement with previous work (18) , two peaks ofinsulin-binding activity with KAVs of0.31 and 0.56, corresponding to apparent Stokes radii of about 7.2 and 3.8 nm, respectively, were detected in the soluble placenta membrane extracts (data not shown). For both the insulin receptor and the basic-SM receptor, the ligand-binding activity and the photolabeled receptor could be adsorbed to and eluted from columns of either concanavalin A-agarose or wheat germ agglutinin-agarose; based on the protein contents of the fractions eluted from the lectin columns, this procedure resulted in about a 30-fold purification of the basic-SM receptor. By using developed methods (16) , it was possible to photolabel both the insulin receptor and the basic-SM receptor in placenta membranes. Upon electrophoretic analysis and autoradioraphy, the major soluble constituent photolabeled with the 1 I-labeled basic-SM photoprobe exhibited a mobility (molecular weight 140,000) very close to that of the photolabeled insulin receptor (Fig. 3) . Photolabeling ofthe basic-SM receptor was virtually abolished in the presence of an excess of unlabeled basic SM, but not in the presence ofunlabeled insulin (Fig. 3, channels a-d) . In the absence of2-mercaptoethanol, the photolabeled basic-SM receptor, like the insulin receptor (21, 22) , migrated upon electrophoresis as a constituent with a molecular weight greater than 240,000 (Fig. 3 , channel e). As noted above, both photolabeled receptors could be adsorbed to and eluted from columns ofconcanavalin A-agarose (Fig. 3 , channels f-i).
The results of preliminary studies with anti-insulin receptor antibody are shown in Table 2 . Studies using soluble placenta membrane preparations, containing primarily basic-SM-binding activity and little insulin-binding activity (a Triton X-100 extract), revealed that little or no basic-SM-binding activity was precipitated with the anti-receptor antibody. In contrast, the anti-receptor antibody was capable of precipitating substantial amounts of insulin receptor either from solubilized rat liver of unlabeled insulin (channel c); e, receptor photolabeled with 1251-labeled basic SM and subjected to electrophoretic analysis in the absence of 2-mercaptoethanol; f and g, analysis of receptor that was first photolabeled with '25I-labeled basic SM and then solubilized for chromatographic analysis by using columns of concanavalin A-agarose (300 ul) as described (16) , showing the electrophoretic-autoradiographic analysis of the unadsorbed fraction (channel f) and the adsorbed material that was eluted from the column with 0.2 M a-Dmethyl-mannopyranoside (channel g); h and i, analysis of insulin receptor that was first photolabeled with 1251-labeled insulin and then solubilized for chromatographic analysis with concanavalin A-agarose columns (300 ,d), showing the unadsorbed fraction (channel h) and the adsorbed material that was eluted from the column with 0.2 M a-Dmethyl-mannopyranoside (channel i). The molecular weight calibration shown x 10-3 applies only to the experiment depicted in channels a and b; human erythrocyte membrane marker proteins were used for calibration. Separate electropherograms are depicted by channels a and b, c-e, and f-i. The relative mobility of the photolabeled receptor, determined in separate experiments, did not differ appreciably. Solubilized placenta (experiments 1 and 2) or rat liver membranes (experiment 1, for insulin binding only) were either used directly (experiment 2, placenta membranes only) or after partial purification with wheat germ agglutinin-Sepharose (experiment 1). In experiment 1, the eluted placenta fractions (100 AD) from wheat germ agglutinin-Sepharose contained SM binding but were devoid of insulin binding; thus an analogous fraction from solubilized liver membranes, eluted from wheat germ agglutinin-Sepharose, was used as an insulin-receptor-containing control. In experiment 2, the placenta extract (0.15% Ammonyx-LO) contained comparable amounts of both insulin-binding and basic-SM-binding activity as indicated by the polyethylene glycol assay. This extract (100 Ml) was used directly for the immunoprecipitation experiment. In experiment 1, extracts were equilibrated with 156,000 cpm of '25I-labeled insulin and 87,800 cpm of "I-labeled basic SM; in experiment 2 samples were equilibrated with 122,000 cpm of 125I-labeled insulin and 132,000 cpm of 125I-labeled basic SM. Immunoprecipitates were counted for 5 min to minimize counting error; values represent the means of duplicate or triplicate determinations that routinely agreed within 10%. In control experiments, it can be demonstrated that no specific radioligand binding is observed in the absence of membrane extract (ref. 23 ; unpublished data).
membranes or from soluble human placenta membrane extracts (Ammonyx-LO) containing large amounts of insulin-binding activity ( Table 2 ). In placenta membrane extracts containing comparable amounts of both insulin receptor and basic-SM receptor, the immunoprecipitation results using radiolabeled basic SM were difficult to interpret because of the appreciable binding of basic SM to the insulin receptor. The results with radiolabeled basic SM were further complicated by the presence in nonimmune rabbit serum of a basic-SM non-receptor binding protein that appears to coprecipitate with the immunoprecipitate.
DISCUSSION
Our studies indicate a striking similarity between the placenta insulin receptor and the receptor for basic SM (similar to IGF-I). Both receptors exhibit a very similar chromatographic behavior (Sepharose 6B) and both photolabeled receptor constituents have virtually the same electrophoretic mobilities in NaDodSO4-containing polyacrylamide gels (molecular weights -140,000 in the presence of 2-mercaptoethanol). Further, upon electrophoretic analysis, both receptors behave as high molecular weight species (>240,000) in the absence ofreducing agent. The ability of both photolabeled receptors to adsorb to the same lectin-agarose columns also may point to similarities in the oligosaccharide moities ofthe two receptor species. These overall properties of the insulin and basic-SM receptors are remarkably different from the characteristics of the receptor for epidermal growth factor-urogastrone, which is also present in the soluble placenta membrane extracts (24) .
The binding competition data unequivocally distinguish between the soluble binding site for basic SM (18, 20, 25) . Finally, it appears that under extraction conditions that yield principally soluble SM-binding activity without insulin-binding activity, no SM-binding activity is precipitated by anti-insulin receptor antibody. Further work will be required to determine unequivocally whether there is some immunological crossreactivity between the receptors for insulin and basic SM. On the whole, our findings are highly suggestive that placental cell membranes contain two distinct but very similar receptor macromolecules (isoreceptors)-one for insulin and another for basic SM. This result is in accord with other data suggesting that the receptors for multiplication-stimulating activity (26) and SM-A (4, 27) are distinct from the receptor for insulin.
We believe that our photolabeling method labels principally the 140,000 molecular weight or a subunit of the insulin-receptor oligomer described by others (21, 22) . Our results indicate the presence of a very similar subunit in the basic-SM receptor. Further studies using peptide-mapping methods to determine the structural homology between the subunits ofthe two receptors may establish the presence or absence ofa IB subunit in the basic SM receptor, similar to the one present in the insulin receptor (28, t) .In addition, further studies comparing the basic-SM receptor with the receptors for the acidic-neutral group of somatomedin (IGF-II, SM-A, and multiplication-stimulating activity) may help to elucidate further the relationship between the various polypeptides with SM-like activities.
